In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
نویسندگان
چکیده
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
منابع مشابه
In vitro drug susceptibility of Chlamydia sp. strain TWAR.
The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic con...
متن کاملPrevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel.
AIMS To evaluate the prevalence of antibodies to Chlamydia pneumoniae (TWAR) in relation to other aetiological agents of acute respiratory infections in Israeli patients. METHOD Serum samples from 604 patients (183 children and 421 adults) were collected over three years. Antibodies to C pneumoniae, C trachomatis, and Legionella sp were evaluated using the microimmunofluorescence (MIF) assay....
متن کاملA new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.
Chlamydia pneumoniae strain TWAR, the new third species of Chlamydia, is a common cause of pneumonia and other acute respiratory tract infections. About 10% of hospitalized and outpatient pneumonia cases have been associated with TWAR infection. TWAR is among the four or five most commonly identified causes of all pneumonia. Most TWAR infections are mild or asymptomatic, but occasionally severe...
متن کاملNasal potentials at high altitude.
Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492–503. 3 Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 1993; 104: 208–213. 4 Johnston SL, Blasi F, Farrell DJ, Nieman RB. Chlamydia pneumoniae infection in patients with acute exacerbations of asthma: the TELICAST study. A...
متن کاملChlamydia in atherosclerosis.
Among the many theories of the pathogenesis of atherosclerosis has been a possible role for infection. However, the possibility that a viral infection initiates or perpetuates damage to the arterial wall has received less attention than other more widely recognized risk factors. Recently, a newly described Chlamydia species, Chlamydia pneumoniae, strain TWAR,' has been associated with atheroscl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Antimicrobial agents and chemotherapy
دوره 33 9 شماره
صفحات -
تاریخ انتشار 1989